Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replication
about
BMS-232632, a highly potent human immunodeficiency virus protease inhibitor that can be used in combination with other available antiretroviral agentsActivities of the human immunodeficiency virus type 1 (HIV-1) protease inhibitor nelfinavir mesylate in combination with reverse transcriptase and protease inhibitors against acute HIV-1 infection in vitroIn vitro combination of PNU-140690, a human immunodeficiency virus type 1 protease inhibitor, with ritonavir against ritonavir-sensitive and -resistant clinical isolatesEfficacy of antiretroviral agents against murine replication-competent retrovirus infection in human cells.Comparison of human immunodeficiency virus type 1 Pr55(Gag) and Pr160(Gag-pol) processing intermediates that accumulate in primary and transformed cells treated with peptidic and nonpeptidic protease inhibitorsCombination antiretroviral therapy and cell-cell spread of wild-type and drug-resistant human immunodeficiency virus-1.Antiretroviral agents inhibit infection of human cells by porcine endogenous retroviruses.In vitro antiviral interaction of lopinavir with other protease inhibitors.Preclinical evaluation of GS-9160, a novel inhibitor of human immunodeficiency virus type 1 integrase.The combined anti-HIV-1 activities of emtricitabine and tenofovir plus the integrase inhibitor elvitegravir or raltegravir show high levels of synergy in vitro.
P2860
Q28344472-7558F5FC-5793-4A7D-ABB0-3873E2200D40Q28379173-6D137588-A193-4C73-83DE-5A401217E86CQ28379223-EDEF2EEB-5B6E-4492-A1BD-77FF731FA29AQ33821343-373BDD5D-4DA6-4471-8A96-8403D90E9772Q33979580-B6AAA491-03E3-4C67-AAB9-98FF487E2089Q38718627-13E9550F-1CFF-4AF7-9AE7-8514E47854EDQ39475754-F03A6193-9C3B-4616-BCD6-25D6FE976885Q39652270-5AA06FCF-F4D2-4A78-8754-CD9A8B794C70Q39902300-6028A5EB-0B14-4BA5-BDE4-EC30A3E858EFQ42932779-30D534BE-8B6B-4A23-9B58-0C95AEA12183
P2860
Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replication
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Evaluation of reverse transcri ...... nodeficiency virus replication
@ast
Evaluation of reverse transcri ...... nodeficiency virus replication
@en
Evaluation of reverse transcri ...... nodeficiency virus replication
@nl
type
label
Evaluation of reverse transcri ...... nodeficiency virus replication
@ast
Evaluation of reverse transcri ...... nodeficiency virus replication
@en
Evaluation of reverse transcri ...... nodeficiency virus replication
@nl
prefLabel
Evaluation of reverse transcri ...... nodeficiency virus replication
@ast
Evaluation of reverse transcri ...... nodeficiency virus replication
@en
Evaluation of reverse transcri ...... nodeficiency virus replication
@nl
P2093
P2860
P1476
Evaluation of reverse transcri ...... nodeficiency virus replication
@en
P2093
C A Deminie
C M Bechtold
M Prichard
R J Colonno
P2860
P304
P407
P577
1996-06-01T00:00:00Z